Join us to learn about the management of common haematological malignancies seen in a critical care setting. The webinar seeks to teach students, doctors and other healthcare professionals about the theory behind CAR-T therapy and the management of patients who are undergoing it.
This webinar brings two expert speakers to discuss aspects of haematology in critical care. Dr Eleni Tholouli, transplant director, director of GM Haem-Onc Pathway Board and consultant haematologist at Manchester University NHS Foundation Trust and Dr Victoria Metaxa, consultant in critical care and major trauma at King's College Hospital in London. She is the medical lead for the critical care outreach team of the Trust as well as the end-of-life ICU lead.
During this session, participants will be able to:
- Understand the key concepts in CAR T-Cell therapy and be able to recognise complications
- Gain insight into the management of patients with haematological malignancies in a critical care setting
The first talk will focus on CAR (Chimeric Antigen Receptor) T-cell therapy, a novel treatment licenced for relapsed refractory DLBCL and paediatric ALL. It requires specialised treatment and ICU plays a significant part in this process. These treatments are currently trialled for many more indications where there is no other treatment available. We will discuss the diagnosis, grading and management of cytokine release syndrome(CRS) and CAR-T related neurotoxicity(ICANS).
The second talk will focus on the management of patients with haematological malignancies in a critical care setting.
A CPD certificate with CPD credit will be issued to those joining the webinar live as well as those who watch the recording afterwards. Certificates will be issued 7 days after the webinar to those who watch it live and after 30 days for those that watch the recording.
This webinar is available for on-demand viewing. The webinar recording will be available for registered delegates up to 30 days after the live webinar broadcast via Zoom. The link will be sent 24 hours after the webinar takes place.
Join in the conversation online #RSMCritCare
Follow us on Twitter: @RoySocMed